Manufacturer record
Pace Biotech: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Pace Biotech (Himachal Pradesh) were declared Not of Standard Quality between May 2024 and September 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Pace Biotech in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Iron Sucrose Injection IP | A23412FMfg 2023-10 · Exp 2025-09 | MisbrandedMisbranded | DTL BaddiState lab | Sep 2025 |
| Iron Sucrose Injection USP 20 mg/ml (I-PIC) | A24105KMfg 2024-06 · Exp 2026-05 | Particulate matter in InjectionsParticulate matter | CDL, KolkataCDSCO lab | Mar 2025 |
| Cefoperazone& Sulbactam for Injection | B- 22680DMfg 2023-01 · Exp 2024-12 | The sample does not conforms to claim as per The Schedule V of The Drugs and Cosmetics Act,1940withrespectto the Test for 'Clarity of solution' and' Particulate matter'Particulate matter | CDL KolkataCDSCO lab | May 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.